A First-in-Human SAD and MAD Study in Healthy Participants to Evaluate Oral YR011 Tablet

计划入组 64 人 · 首次发布于 2025 年 12 月 16 日

Renal Efficacy and Safety of the Novel Oral Small-Molecule GLP-1RA HRS-7535 Evaluated in Participants With Chronic Kidney Disease

计划入组 3,690 人 · 首次发布于 2026 年 6 月 4 日

NANT 2015-02: A Phase 1 Study of Lorlatinib (PF-06463922)

计划入组 65 人 · 首次发布于 2017 年 4 月 11 日

HFrEF therapeutic (oral, small molecule)

small molecule (oral, Duchenne muscular dystrophy associated cardiomyopathy)

small molecule therapeutics (oral, smallpox)

Odyssey Therapeutics

RAPT Therapeutics

United States

BioCryst Pharmaceuticals

Immunic's Vidofludimus Calcium Shows Promise in Multiple Sclerosis Treatment

AstraZeneca Unveils Oral Small Molecule PCSK9 Inhibitor AZD0780

Structure Therapeutics to Release Pivotal Data for Oral GLP-1 Obesity Drug Aleniglipron